Your browser doesn't support javascript.
loading
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.
Bousquet, J Jean; Schünemann, Holger J; Togias, Alkis; Erhola, Marina; Hellings, Peter W; Zuberbier, Torsten; Agache, Ioana; Ansotegui, Ignacio J; Anto, Josep M; Bachert, Claus; Becker, Sven; Bedolla-Barajas, Martin; Bewick, Michael; Bosnic-Anticevich, Sinthia; Bosse, Isabelle; Boulet, Louis P; Bourrez, Jean Marc; Brusselle, Guy; Chavannes, Niels; Costa, Elisio; Cruz, Alvaro A; Czarlewski, Wienczyslawa; Fokkens, Wytske J; Fonseca, Joao A; Gaga, Mina; Haahtela, Tari; Illario, Maddalena; Klimek, Ludger; Kuna, Piotr; Kvedariene, Violeta; Le, L T T; Larenas-Linnemann, Desiree; Laune, Daniel; Lourenço, Olga M; Menditto, Enrica; Mullol, Joaquin; Okamoto, Yashitaka; Papadopoulos, Nikos; Pham-Thi, Nhân; Picard, Robert; Pinnock, Hilary; Roche, Nicolas; Roller-Wirnsberger, Regina E; Rolland, Christine; Samolinski, Boleslaw; Sheikh, Aziz; Toppila-Salmi, Sanna; Tsiligianni, Ioanna; Valiulis, Arunas; Valovirta, Erkka.
Afiliación
  • Bousquet JJ; MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU, 34295 Montpellier Cedex 5, France.
  • Schünemann HJ; 2INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France.
  • Togias A; European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
  • Erhola M; 4Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Berlin, Germany.
  • Hellings PW; 6Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON Canada.
  • Zuberbier T; 7Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA.
  • Agache I; 8National Institute for Health and Welfare, Helsinki, Finland.
  • Ansotegui IJ; European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
  • Anto JM; 9Dept of Otorhinolaryngology, Univ Hospitals Leuven, Louvain, Belgium.
  • Bachert C; 10Academic Medical Center, Univ of Amsterdam, Amsterdam, The Netherlands.
  • Becker S; 4Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Berlin, Germany.
  • Bedolla-Barajas M; 5Department of Dermatology and Allergy Member of GA2LEN, Comprehensive Allergy-Centre, Berlin Institute of Health, Berlin, Germany.
  • Bewick M; 11Faculty of Medicine, Transylvania University, Brasov, Romania.
  • Bosnic-Anticevich S; Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain.
  • Bosse I; ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Boulet LP; 14IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
  • Bourrez JM; 15CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Brusselle G; 16Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Chavannes N; 17Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium.
  • Costa E; 18Dept of Otolaryngology, Head and Neck Surgery, University of Mainz, Mainz, Germany.
  • Cruz AA; 19Hospital Civil de Guadalajara Dr Juan I Menchaca, Guadalarara, Mexico.
  • Czarlewski W; iQ4U Consultants Ltd, London, UK.
  • Fokkens WJ; 21Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.
  • Fonseca JA; Woolcock Emphysema Centre, Sydney, Australia.
  • Gaga M; Sydney Local Health District, Glebe, NSW Australia.
  • Haahtela T; La Rochelle, France.
  • Illario M; 25Quebec Heart and Lung Institute, Laval University, Quebec City, QC Canada.
  • Klimek L; EIT Health France, Paris, France.
  • Kuna P; 27Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Kvedariene V; 28Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Le LTT; 29UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal.
  • Larenas-Linnemann D; 30ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
  • Laune D; WHO GARD Planning Group, Salvador, Brazil.
  • Lourenço OM; Medical Consulting Czarlewski, Levallois, France.
  • Menditto E; European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
  • Mullol J; 33Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands.
  • Okamoto Y; 34CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Papadopoulos N; Medida, Lda Porto, Portugal.
  • Pham-Thi N; ERS President 2017-2018, Athens Chest Hospital, 7th Resp Med Dept and Asthma Center, Athens, Greece.
  • Picard R; 37Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Pinnock H; Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R &D and DISMET), Naples, Italy.
  • Roche N; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Roller-Wirnsberger RE; 40Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lódz, Poland.
  • Rolland C; 41Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Samolinski B; 42University of Medicine and Pharmacy, Hochiminh City, Vietnam.
  • Sheikh A; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
  • Toppila-Salmi S; KYomed INNOV, Montpellier, France.
  • Tsiligianni I; 45Faculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Valiulis A; 46CIRFF, Federico II University, Naples, Italy.
  • Valovirta E; 47Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona, Spain.
Clin Transl Allergy ; 9: 44, 2019.
Article en En | MEDLINE | ID: mdl-31516692
BACKGROUND: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. MAIN BODY: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. CONCLUSION: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Transl Allergy Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Transl Allergy Año: 2019 Tipo del documento: Article País de afiliación: Francia